Sanofi India’s MD Rajaram Narayanan exits

Sanofi India has announced that its Board of Directors have accepted the resignation of its Managing Director, Rajaram Narayanan, effective on April 10, 2022. Narayanan has decided to pursue an opportunity outside of Sanofi. His successor will be appointed in due course. He joined the company in

2014 as General Manager and was later elevated as Country Lead & Managing Director. In these roles, he has led the strategic reorientation of the organisation, sharpening its focus on core areas, developing new business models, building future talent and driving digital transformation across all areas of the business. The company also took significant steps to streamline its portfolio, supply footprint and go-to-market operations. He leaves behind a strong leadership team to steer the company forward. Narayanan will be joining Mumbai-based animal healthcare company SeQuent Scientific. He will oversee the company’s next phase of growth and expansion. SeQuent is backed by global investment firm Carlyle.